FIGURE 3-1. Global TB drug pipeline, as of June 18, 2012.

FIGURE 3-1Global TB drug pipeline, as of June 18, 2012

NOTE: GLP, Good Laboratory Practices; Tox., toxicity.

ab

SOURCE: Kimerling, 2012. Presentation at IOM workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis.

From: 3, Financing of MDR TB SLDs

Cover of Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis
Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis: Workshop Summary.
Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation.
Washington (DC): National Academies Press (US); 2013.
Copyright © 2013, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.